Flutamide News and Research

RSS
The efficacy and safety of anti-androgens in the management of hormonal and clinical features of PCOS

The efficacy and safety of anti-androgens in the management of hormonal and clinical features of PCOS

Polygenic risk score can predict risk of drug-induced liver injury

Polygenic risk score can predict risk of drug-induced liver injury

Abiraterone can prolong overall survival and delay severe pain in prostate cancer patients

Abiraterone can prolong overall survival and delay severe pain in prostate cancer patients

First report of androgen-dependence of exercise on nerve regeneration

First report of androgen-dependence of exercise on nerve regeneration

Clinical trial to examine effectiveness of combined vaccine and hormone treatment for prostate cancer

Clinical trial to examine effectiveness of combined vaccine and hormone treatment for prostate cancer

Radiation induces testicular cancer in male fetuses

Radiation induces testicular cancer in male fetuses

Mix of endocrine disrupters a dangerous cocktail

Mix of endocrine disrupters a dangerous cocktail

Benefits of short-term hormonal therapy for men receiving radiation therapy for prostate cancer far outweigh the risks

Benefits of short-term hormonal therapy for men receiving radiation therapy for prostate cancer far outweigh the risks

Monitoring anemia provides clues to prostate cancer treatment response

Monitoring anemia provides clues to prostate cancer treatment response

Cancer vaccine combined with hormone-deprivation therapy can help patients with recurrence of prostate cancer

Cancer vaccine combined with hormone-deprivation therapy can help patients with recurrence of prostate cancer

Australian-New Zealand hormone therapy trial good news for prostate cancer patients

Australian-New Zealand hormone therapy trial good news for prostate cancer patients

Phase II trials of the first second-generation antisense cancer drug to be used in patients soon to be underway

Phase II trials of the first second-generation antisense cancer drug to be used in patients soon to be underway

The April 2004 issue of Otolaryngology focuses on head and neck surgery

The April 2004 issue of Otolaryngology focuses on head and neck surgery

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.